Related Experiment Video
Updated: Jan 23, 2026

Measuring the Functional Abilities of Children Aged 3-6 Years Old with Observational Methods and Computer Tools
Published on: June 20, 2020
[Evaluation of the influenza vaccine effectiveness among children aged 6 to 72 months based on the test-negative case
1Department of Immunization Program, Yiwu Municipal Center for Disease Control and Prevention, Yiwu 322000, China.
Insights
The seasonal influenza vaccine demonstrated 58% effectiveness in children aged 6-72 months across two flu seasons. Vaccine effectiveness was higher in older children (36-72 months) compared to younger children (6-35 months).
Area of Science:
- Pediatric infectious diseases
- Vaccinology
- Public health surveillance
Background:
- Seasonal influenza poses a significant health risk to children globally.
- Vaccination is a primary strategy for influenza prevention.
- Assessing vaccine effectiveness (VE) in pediatric populations is crucial for public health policy.
Purpose of the Study:
- To evaluate the effectiveness of the seasonal influenza vaccine in children aged 6 to 72 months.
- To compare VE across different age strata within the pediatric population.
- To analyze VE for specific influenza virus types and across different seasons.
Main Methods:
- A test-negative case-control study utilizing surveillance data from the China Influenza Surveillance Information System (CSIS).
- Inclusion of 1,161 children aged 6-72 months with influenza-like illness from October 2016 to April 2018.
- Multivariate logistic regression and propensity score methods were employed to estimate vaccine effectiveness.
Main Results:
- Overall VE against all influenza types combined was 58% (95% CI: 31%-74%) for the two seasons.
- VE was significantly higher in children aged 36-72 months (68%; 95% CI: 41%-82%) compared to those aged 6-35 months (28%; 95% CI: -80%-71%).
- VE against influenza A (H3N2) was 65% (95% CI: 24%-83%) during the 2016-2017 season.
Conclusions:
- The seasonal influenza vaccine is effective in preventing influenza virus infection in children.
- Vaccine effectiveness is notably higher in children aged 36-72 months.
- Findings support continued influenza vaccination programs for children, with potential age-specific considerations.
Abstract:
Objective: To assess the effectiveness of seasonal influenza vaccine among children aged 6 to 72 months. Methods: The test-negative case control study was conducted based on available surveillance data which was from China Influenza Surveillance Information system (CSIS). From October 2016 to April 2017 and from October 2017 to April 2018,1 161 cases aged 6-72 months with influenza-like illness in Yongkang and Yiwu city, were selected as the study subjects, and the cases with influenza test-positive were selected as the case group (403 cases). Test-negative subjects were selected as control group (758 cases). The etiology and immunization data of the subjects were obtained from CSIS and Immune Information and Management System (IIMS) respectively. Vaccine effectiveness was estimated using multivariate logistic regression model,and the mixed effects of non-randomized control in TNCC study were equalized by using the propensity score (PS) method in the statistical analysis. Results: The age of the subjects was (2.44±1.60) years,and there were 681 boys (58.66%). The age of case group was (2.62±1.58) years, and there were 246 boys (61.04%). The case group was including of 237 cases (58.81%) of influenza A (H3N2), 92 cases (22.83%) of influenza A (H1N1) pmd09, 62 cases (15.38%) of influenza B(Victoria) lineage, 11 cases (2.73%) of influenza B (Yamagata) lineage and one case (0.25%) co-infection of influenza [A(H(3)N(2))+B (Victoria)]. The mean age of the control group was (2.35±1.61) years,and there were 435 boys (57.39%). Overall vaccine effectiveness (VE) against all type influenza for two seasons combined was 58% (95%CI: 31%-74%). An analysis by age groups showed 68% (95%CI:41%-82%) of the VE estimate among children aged 36-72 months while it was 28%(95%CI:-80%-71%)of the VE estimate among children aged 6-35 months. The VE estimate value was 54% (95%CI:16%-75%) against all type influenza and 65% (95%CI:24%-83%) against influenza A (H(3)N(2)) during the 2016-2017 season. During the 2017-2018 season, the VE estimate value was 69% (95%CI:18%-88%) against all type influenza. Conclusion: Influenza vaccine is effective in preventing influenza virus infection during the flu season,especially the effect among children aged 36-72 months is higher compared to that among children aged 6-35 months.
More Related Videos
10:39Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Related Concept Videos
Vaccinations
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
PI Controller: Design
Pharmacodynamics in Geriatric Patients: Effects of Age
Group Design
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...